Get the Stockscreener App
7.60
5.26%
0.38
Lifecore Biomedical Inc stock is traded at $7.60, with a volume of 119.68K.
It is up +5.26% in the last 24 hours and up +2.15% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$7.22
Open:
$7.29
24h Volume:
119.68K
Relative Volume:
0.64
Market Cap:
$284.30M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
152.00
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
+3.12%
1M Performance:
+2.15%
6M Performance:
+35.47%
1Y Performance:
+33.10%
1-Day Range:
$7.29
$7.63
1-Week Range:
$7.12
$7.63
52-Week Range:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.60 | 276.82M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Live market analysis of Lifecore Biomedical Inc.Market Risk Report & Reliable Volume Spike Alerts - Newser
Automated trading signals detected on Lifecore Biomedical Inc.2025 Earnings Impact & Expert Approved Momentum Trade Ideas - Newser
MACD Cross Could Confirm Trend in Lifecore Biomedical Inc.July 2025 Sentiment & Consistent Profit Trade Alerts - newsyoung.net
Technical Charts Suggest Momentum Shift in Lifecore Biomedical Inc.2025 Valuation Update & AI Driven Price Forecasts - beatles.ru
How sentiment analysis helps forecast Lifecore Biomedical Inc.Weekly Market Summary & Expert Approved Momentum Ideas - Newser
What data driven models say about Lifecore Biomedical Inc.’s futureJuly 2025 Final Week & Community Consensus Stock Picks - Newser
Can machine learning forecast Lifecore Biomedical Inc. recoveryMarket Growth Report & Community Consensus Picks - Newser
What to expect from Lifecore Biomedical Inc. in the next 30 daysEarnings Miss & High Return Trade Opportunity Guides - Newser
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
How to manage a losing position in Lifecore Biomedical Inc.Weekly Trade Summary & Real-Time Buy Signal Notifications - Newser
What the charts say about Lifecore Biomedical Inc. today2025 Market Sentiment & Risk Managed Trade Strategies - Newser
Analyzing Lifecore Biomedical Inc. with multi timeframe chartsQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What Fibonacci levels say about Lifecore Biomedical Inc. reboundPortfolio Gains Summary & Low Risk High Win Rate Picks - Newser
Using data models to predict Lifecore Biomedical Inc. stock movementGlobal Markets & Proven Capital Preservation Tips - Newser
Volume spikes in Lifecore Biomedical Inc. stock – what they meanGold Moves & Technical Pattern Recognition Alerts - Newser
Technical analysis overview for Lifecore Biomedical Inc. stockMarket Activity Recap & Entry Point Confirmation Signals - Newser
Is Lifecore Biomedical Inc. forming a bullish divergence2025 Growth vs Value & AI Forecast for Swing Trade Picks - mustnews.co.kr
Momentum divergence signals in Lifecore Biomedical Inc. chartQuarterly Trade Report & High Win Rate Trade Tips - Newser
Tools to monitor Lifecore Biomedical Inc. recovery probabilityWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser
Is Lifecore Biomedical Inc. stock a good hedge against inflation2025 Market Sentiment & Community Consensus Trade Alerts - Newser
Signal strength of Lifecore Biomedical Inc. stock in tech scanners2025 Volume Leaders & Accurate Technical Buy Alerts - Newser
Lifecore Biomedical Inc. stock chart pattern explained2025 Technical Overview & High Accuracy Swing Entry Alerts - Newser
Custom strategy builders for tracking Lifecore Biomedical Inc.July 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
Should you hold or exit Lifecore Biomedical Inc. nowTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsBond Market & Long-Term Safe Investment Plans - Newser
Is Lifecore Biomedical Inc. the Top Chart Pick This WeekJuly 2025 Selloffs & Free Long-Term Investment Growth Plans - newsyoung.net
Sector Rotation Brings Lifecore Biomedical Inc. Into FocusWeekly Trend Summary & Consistent Profit Trade Alerts - beatles.ru
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - ACCESS Newswire
How does Lifecore Biomedical Inc. perform in inflationary periodsTrade Risk Report & Risk Adjusted Buy/Sell Alerts - sundaytimes.kr
XTX Topco Ltd Takes $145,000 Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical: Promising Growth Strategy and 30% Upside Potential Justifies Buy Rating - TipRanks
Short interest data insights for Lifecore Biomedical Inc.Quarterly Investment Outlook and Key Summary - Newser
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Using Ichimoku Cloud for Lifecore Biomedical Inc. technicalsTechnical Insight Guide for Safer Trades - Newser
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates - msn.com
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingPredictable Return Strategy with AI Support - Newser
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifecore Biomedical Inc Stock (LFCR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):